icon-    folder.gif   Conference Reports for NATAP  
 
  22nd Conference on Retroviruses and
Opportunistic Infections
Seattle Washington Feb 23 - 26, 2015
Back grey_arrow_rt.gif
 
 
 
Consistency of Dolutegravir
Treatment Difference in HIV+ Treatment Naives at Week 96
 
 
  Reported by Jules Levin
 
CROI 2015 Feb 23-26, Seattle, WA
 
Catherine Granier1, Naomi Givens1, Robert Cuffe2, Michael Aboud2, Louise Martin-Carpenter3, Kimberly Smith3, Clare Brennan4, Keith Pappa4, Brian Wynne4, Steve Almond5
1 R&D, GlaxoSmithKline, Uxbridge, Middlesex, United Kingdom;2 ViiV Healthcare, London, United Kingdom;3 ViiV Healthcare, Research Triangle Park, North Carolina, United States;4 GlaxoSmithKline, Research Triangle Park, North Carolina, United States;5 GlaxoSmithKline, Mississauga, Ontario, Canada

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif